Results 11 to 20 of about 98,705 (330)

BERAPA KEBUTUHAN DIAZEPAM UNTUK MEMENUHI PELAYANAN KESEHATAN DI INDONESIA? STUDI KASUS KONSUMSI DIAZEPAM DI INDONESIA [PDF]

open access: yesJurnal Manajemen dan Pelayanan Farmasi, 2016
Diazepam adalah obat esensial golongan benzodiazepin yang penggunaannya diawasi secara nasional dan global, oleh karena itu  ketersediaan untuk pelayanan kesehatan harus dapat terpenuhi.
Nunung Priyatni W
doaj   +3 more sources

Comparative efficacy of Diazepam, Ketamine, and Diazepam-Ketamine combination for sedation or anesthesia in cockerel chickens

open access: yesJournal of Advanced Veterinary and Animal Research, 2014
The comparative efficacy of Diazepam, Ketamine, and Ketamine-Diazepam combination was assessed in adult chickens. The chickens (n=30) were divided into three equal groups (G-1, G-2 and G-3), and were administered with Diazepam dosed at 0.5 mg/kg body ...
Muhammad Abdullahi Mahmud   +5 more
doaj   +2 more sources

Sedative Effects of Intraperitoneal Diazepam in Mice

open access: yesInternational Journal of Integrated Health Sciences, 2023
Objectives: To determine the effectiveness of Diazepam in comparison with Phenobarbital. Methods: Twenty-seven male Swiss Webster mice were used and randomly divided into three groups of negative control (NS), positive control (Phenobarbital), and ...
Marsha Vania   +3 more
doaj   +1 more source

Pharmacodynamic and pharmacokinetic effects of flumazenil and theophylline application in rats acutely intoxicated by diazepam [PDF]

open access: yesVojnosanitetski Pregled, 2009
Background/Aim. The majority of symptoms and signs of acute diazepam poisoning are the consequence of its sedative effect on the CNS affecting selectively polisynaptic routes by stimulating inhibitory action of GABA.
Šegrt Zoran   +7 more
doaj   +1 more source

VALTOCO® (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

open access: yesNeurology International, 2021
Valtoco® is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older.
Elyse M. Cornett   +8 more
doaj   +1 more source

Synergistic effects of applying static magnetic fields and diazepam to improve EEG abnormalities in the pilocarpine epilepsy rat model

open access: yesScientific Reports, 2023
The lithium-pilocarpine rat model is a well-known model of temporal epilepsy. Recently we found that transcranial static magnetic stimulation (tSMS) delay and reduce the signs of EEG in this model.
Carmen de Labra   +2 more
doaj   +1 more source

A bibliometric analysis of the recent advances in diazepam from 2012 to 2021

open access: yesFrontiers in Pharmacology, 2022
Background: Diazepam is a classic benzodiazepine drug that has been widely used for disorders such as anxiety, sleep disorders, and epilepsy, over the past 59 years. The study of diazepam has always been an important research topic.
Ming Zhang   +7 more
doaj   +1 more source

Determination of diazepam and its metabolites in serum by the use of liquid chromatography: Mass spectrometry method [PDF]

open access: yesVojnosanitetski Pregled, 2007
Background/Aim. Diazepam is a benzodiazepine anxyolitic. Metabolism of diazepam takes place in liver which generates pharmacologically active metabolites N-desmethyldiazepam, temazepam and oxazepam.
Đorđević Snežana, Kilibarda Vesna
doaj   +1 more source

Biochemical and toxicological effect of diazepam in stress-induced cardiac dysfunctions

open access: yesToxicology Reports, 2020
Diazepam is a medicine of the family benzodiazepine, used to treat various CNS disorders. To date, no study is available for biochemical analysis of diazepam in cardiac dysfunction.
Fahad A. Al-Abbasi   +2 more
doaj   +1 more source

Is diazepam an antidepressant? [PDF]

open access: yesBritish Journal of Psychiatry, 1989
In double-blind sequential study, diazepam was compared with the proven antidepressant moclobemide, in patients with atypical depression. Both agents significantly improved depression ratings over eight weeks of treatment. Diazepam was a significantly better antidepressant than moclobemide at four weeks, although not at eight weeks. All patients ceased
J W, Tiller   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy